posaconazole
posaconazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: posaconazole; Generic name: POSACONAZOLE; Drug class: Azole Antifungal [EPC].
| Brand name | posaconazole |
|---|---|
| Generic name | POSACONAZOLE |
| Drug class | Azole Antifungal [EPC] |
| Manufacturer | Novadoz Pharmaceuticals LLC |
| Used for | 1 INDICATIONS AND USAGE Posaconazole is an azole antifungal indicated as follows: Posaconazole is indicated for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy as follows: ( 1.2 ) o Posaconazole delayed-release tablets: adults and pediatric patients 2 years of age and older who weigh greater than 40 kg 1.2 Prophylaxis of Invasive Aspergillus and Candida Infections Posaconazole delayed-release t |
| Dosage | 2 DOSAGE AND ADMINISTRATION Noxafil ® oral suspension is not substitutable with posaconazole delayed-release tablets or Noxafil ® PowderMix for delayed-release oral suspension due to the differences in the dosing of each formulation. Therefore, follow the specific dosage recommendations for each of the formulations. ( 2.1 , 2.2 , 2.3 ) Administer posaconazole delayed-release tablets with or without food. ( 2.1 ) Table 1: Recommended Dosage in Adult Patients Indication Dosage Form, Dose, and Dura |
| Active ingredient(s) | POSACONAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bdf77ae-3639-49c1-b7c7-533f9d073084 |